Skip to content

Clinical trials

Completed Phase 2/3 COVID-19 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2/3 Status: Completed Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202054
202128
202215
20237
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioNTech SE4
ModernaTX, Inc.4
Novavax3
AstraZeneca2
Australian National University2
Cambridge University Hospitals NHS Foundation Trust2
Cellular Sciences, inc.2
D'Or Institute for Research and Education2
Dr. Ferrer BioPharma2
Hipra Scientific, S.L.U2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19105
Coronavirus Infections23
Virus Diseases7
Pneumonia5
Post-Acute COVID-19 Syndrome3
Respiratory Distress Syndrome3
Cytokine Release Syndrome2
Inflammation2
Respiratory Insufficiency2
Severe Acute Respiratory Syndrome2

Trials

Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.